Home/ Stocks/ HCWB

HCW Biologics Inc. Common Stock

HCWB XNAS

$0.43 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$1.82M

About HCW Biologics Inc. Common Stock

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 36 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$15.6K	$-4,554,336	$-2.02
Q2 2025	$6.5K	$-1,927,730	$-6.79
Q1 2025	$5.1K	$-2,196,875	$-0.05
FY 2024	$2.57M	$-30,023,814	$-0.77

TickerDaily Coverage

Why Is HCW Biologics Inc. Common Stock (HCWB) Stock Up 54.7% Today?

Penny Stocks Marcus Rivera · Mar 16, 2026

HCW Biologics (HCWB) stock exploded 54.7% higher today after announcing a $1.5 million follow-on...

View All Coverage →

Get HCWB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on HCW Biologics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.